Document is current
Any future updates will be listed below
-
Authors
Jaiswal, Raju
Zoulakis, Michail
Axelsson, Kristian F.
Litsne, Henrik
Johansson, Lisa
Lorentzon, Mattias https://orcid.org/0000-0003-0749-1431
-
Funding
Funding for this research was provided by:
Vetenskapsrådet
Sahlgrenska Universitetssjukhuset
IngaBritt och Arne Lundbergs Forskningsstiftelse
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
University of Gothenburg
- License Information
-
More Information
Article History
Received: 8 September 2025
Accepted: 4 April 2026
First Online: 20 April 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: None.
: Dr. Johansson received lecture fees from UCB Pharma outside the scope of this work. Dr. Axelsson received personal fees from Amgen, Meda/Mylan, also outside the scope of this work. Professor Lorentzon has received lecture fees from Amgen, Astellas, Meda, Jansen-Cilag, Medison Pharma, Gedeon Richter, UCB Pharma, and consulting fees from Amgen, UCB Pharma, Medac, Gedeon Richter, Sandoz, Crinetics, Pharmacosmos, all outside the presented research. No other conflicts of interest were reported.
